Estimating attributable mortality due to nosocomial infections acquired in intensive care units

Infection Control and Hospital Epidemiology

Volumn 31, Issue 4, 2010, Pages 388-394

  Januel, Jean Marie ^a,e   Harbarth, Stephan ^f   Allard, Robert ^g   Voirin, Nicolas ^a   Lepape, Alain ^b   Allaouchiche, Bernard ^b   Guerin, Claude ^b   Lehot, Jean Jacques ^b   Robert, Marc Olivier ^b   Fournier, Gérard ^b   Jacques, Didier ^b   Chassard, Dominique ^b   Gueugniaud, Pierre Yves ^b   Artru, François ^b   Petit, Paul ^b   Robert, Dominique ^b   Mohammedi, Ismaël ^b   Girard, Raphaëlle ^c   Cêtre, Jean Charles ^c   Nicolle, Marie Christine ^c   Grando, Jacqueline ^c   Fabry, Jacques ^a,d   Vanhems, Philippe ^a,d   more..

^a UNIVERSITÉ LYON 1   (France)

^b Department of Flow Cytometry   (France)

^c Infection Control Units   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g Infectious Diseases Unit   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOODSTREAM INFECTION; CASE CONTROL STUDY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; FRANCE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; URINARY TRACT INFECTION;

CASE-CONTROL STUDIES; CAUSE OF DEATH; CRITICAL ILLNESS; CROSS INFECTION; FRANCE; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; POPULATION SURVEILLANCE; RISK;

EID: 77949550954     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/650754     Document Type: Article

References (43)

1. Eggimann P, Pittet D. Infection control in the ICU. Chest 2001;120:2059- 2093.
2. Vincent JL. Nosocomial infections in adult intensive-care units. Lancet 2003; 361:2068-2077.
3. Safdar N, Dezfulian C, Colard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33:2184-2193.
4. Girou E, Stephan F, Novara A, Safar M, Fagon JY. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med 1998;157:1151-1158.
5. Sanchez-Velazquez LD, Ponce de Leon Rosales S, Rangel Frausto MS. The burden of nosocomial infection in intensive care unit: effects on organ failure, mortality and costs-a nested case-control study. Arch Med Res 2006;37:370-375.
6. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medicalsurgical intensive care units in Argentina: attributable mortality and length of stay (published correction appears in Am J Infect Control 2003;31:409). Am J Infect Control 2003;31:291-295.
7. Blot S, De Bacquer D, Hoste E, et al. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients. Infect Control Hosp Epidemiol 2005;26:352- 356.
8. Garrouste-Orgeas M, Timsit JF, Tafflet M, et al. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal (published correction appears in Clin Infect Dis 2006;42:1818). Clin Infect Dis 2006;42:1118-1126.
9. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributablemortality. JAMA 1994;271:1598-1601.
10. Fagon JY, Novara A, Stephan F, Giroud E, Safar M. Mortality attributable to nosocomial infections in the ICU. Infect Control Hosp Epidemiol 1994;15: 428-434.
11. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999;20:396-401.
12. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995;274:639- 644.
13. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1998.
14. Garcia-Martin M, Lardelli-Claret P, Jiménez-Moleon JJ, Buenos-Cavanillas A, Luna-del-Castillo JD, Galvez-Vargas R. Proportion of hospital deaths potentially attributable to nosocomial infection. Infect Control Hosp Epidemiol 2001;22:708-714.
15. Fabbro-Peray P, Sotto A, Defez C, et al. Mortality attributable to nosocomial infection: a cohort of patients with and without nosocomial infection in a French university hospital. Infect Control Hosp Epidemiol 2007;28:265- 272.
16. Gail MH. A bibliography and comments on the use of statistical models in epidemiology in the 1980s. Stat Med 1991;10:1819-1885.
17. Savey A, Lepape A, Tressière B, Ayzac L, Fabry J. ICUs-AI for the Southeast of France. Surveillance network protocol. C. CLIN Sud-Est [in French]. http://cclin-sudest.chu-lyon.fr/Reseaux/REA/. Accessed June 2009.
18. Vanhems P, Lepape A, Savey A, Jambou P, Fabry J. Nosocomial pulmonary infection by antimicrobial-resistant bacteria of patients hospitalized in intensive care units: risk factors and survival. J Hosp Infect 2000;45:98-106.
19. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985;122:904-914.
20. Le Gall JR, Loirat P, Alperovitch A, et al. A simplified acute physiology score for ICU patients. Crit Care Med 1984;12:975-977.
21. Salemi C, Morgan J, Padilla S, Morrissey R. Association between severity of illness and mortality from nosocomial infection. Am J Infect Control 1995; 23:188-193.
22. Suetens C, Savey A, Labeeuw J, Morales I; HELICS-ICU. The ICU-HELICS Programme: towards European surveillance of hospital-acquired infections in intensive care units. Euro Surveill 2002;7:127-128.
23. Gardner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. In: Olmsted RN, ed. APIC Infection Control and Applied Epidemiology: Principles and Practice. St Louis, MO: Mosby; 1996: A1-A20.
24. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 1974;99:325-332.
25. Wacholder S, Benichou J, Heineman EF, Hartge P, Hoover RN. Attributable risk: advantages of a broad definition of exposure.Am J Epidemiol 1994;140: 303-309.
26. Hanley JA. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health 2001;55:508-514.
27. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998;88:15-19.
28. Kuritz SJ, Landis JR. Attributable risk ratio estimation frommatched-pairs case-control data. Am J Epidemiol 1987;125:324-328.
29. Kuritz SJ, Landis JR. Attributable risk estimation frommatched case-control data. Biometrics 1988;44:355-367.
30. Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics 1976;32:829-849.
31. Poole C. Exposure opportunity in case-control studies. Am J Epidemiol 1986;123:352-358.
32. Kuritz SJ, Landis JR. Re: "Exposure opportunity in case-control studies". Am J Epidemiol 1987;125:1095-1096.
33. Bland JM, Altman DG. The odds ratio. BMJ 2000;320:1468.
34. Kelsey JL, Whittemore AS, Evans AS, Thompson WD. Methods in observational epidemiology. 2nd ed. New York, NY: Oxford University Press; 1996.
35. Doll R, Hill AB. Smoking and carcinoma of the lung. Br Med J 1950;221: 739-748.
36. Levin MI, Goldstein H, Gerhardt PR. Cancer and tobacco smoking. J Am Med Assoc 1950;143:336-338.
37. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847-852.
38. de Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009;360: 20-31.
39. Samore MH, Harbarth S. A methodologically focused review of the literature in hospital epidemiology and infection control. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:1645-1657.
40. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953;9:531-541.
41. Moalla M, Baratin D, Giard M, Vanhems P. Incidence of methicillin-resistant Staphylococcus aureus nosocomial infections in intensive care units in Lyon University hospitals, France, 2003-2006. Infect Control Hosp Epidemiol 2008;29:454-456.
42. Macgowan AP; BSAC Working Parties on Resistance Surveillance. Clinical implications of antimicrobial resistance for therapy. J Antimicrob Chemother 2008;62(Suppl 2):S105-S114.
43. Blot S, Depuydt P, Vandewoude K, De Bacquer D. Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis 2007; 20:391-396.